Autres langues Applied Therapeutics, Inc.

Actions

APLT

US03828A1016

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
4,28 ^USD	+1,18 %		-2,28 %	+27,76 %

15/04	Applied Therapeutics, Inc. annonce des changements de direction	CI
28/03	Applied Therapeutics obtient une extension de la période d'examen de la NDA pour le traitement de la galactosémie -- Les actions chutent après les heures d'ouverture	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer	15/04
Applied Therapeutics, Inc. Announces Management Changes	15/04
Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024	04/04
Applied Therapeutics Shares Slip 13% After FDA Extends Drug Review	28/03
FDA Extends Review Period for Applied Therapeutics Genetic Disease Treatment	28/03
Applied Therapeutics Gets NDA Review Period Extension for Galactosemia Treatment -- Shares Fall After Hours	28/03
US FDA extends review of Applied Therapeutics' genetic disease drug	28/03
Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia	28/03
Applied Therapeutics, Inc. Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia	28/03
Applied Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Earnings Flash (APLT) APPLIED THERAPEUTICS Reports Q4 Revenue $10M	06/03
Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results	06/03
Applied Therapeutics, Inc. announced that it has received $99.997998 million in funding from a group of investors	01/03
Applied Therapeutics' NDA for Govorestat Accepted by FDA; Launches $100 Million Private Placement; Shares Jump	28/02
Applied Therapeutics Shares Surge on FDA Review, $100 Million Funding Round	28/02
Applied Therapeutics Announces $100 Million Private Placement	28/02
Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia	28/02
Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia	28/02
Sector Update: Health Care Stocks Higher Late Afternoon	16/02
Sector Update: Health Care	16/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Applied Therapeutics, Inc.

Actions

APLT

US03828A1016

Autres langues

Filtres